We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Bacteriophage Infection Mediated by Molecules from Susceptible Organisms

By LabMedica International staff writers
Posted on 26 Jan 2017
A team of Israeli molecular microbiologists has found that bacteria that are resistant to infection by bacteriophages can lose this resistance when incubated together with susceptible bacteria.

The mechanism by which bacteria that are resistant to infection by phages become susceptible had not been well studied. More...
To elucidate this mechanism, investigators at The Hebrew University of Jerusalem investigated phage dynamics in communities harboring phage-resistant (R) and sensitive (S) Bacillus subtilis bacteria.

Using cultures of B. subtilis and its lytic phage SPP1, they demonstrated that R cells, lacking SPP1 receptor, could be lysed by SPP1 when co-cultured with S cells. This unanticipated lysis was triggered in part by phage lytic enzymes released from nearby infected cells. They also discovered that occasionally phages could invade R cells, a phenomenon they termed acquisition of sensitivity (ASEN).

The investigators reported in the January 12, 2017, issue of the journal Cell that ASEN was mediated by R cells transiently gaining phage attachment molecules from neighboring S cells and that this molecular exchange was driven by membrane vesicles. They speculated that this exchange of phage attachment molecules could even occur in an interspecies fashion, enabling phage adsorption to non-host species, providing an unexplored route for horizontal gene transfer (HGT).

"In the present study, we show for the first time how bacteria entirely resistant to a given phage become susceptible upon co-incubation with sensitive bacteria. Phage invasion into resistant cells could have a major impact on transfer of antibiotic resistance and virulence genes among bacteria. This aspect should be carefully considered when employing phage therapy, as phage infection of a given species may result in gene transmission into neighboring bacteria resistant to the phage," said senior author Dr. Sigal Ben-Yehuda, professor of microbiology and molecular genetics at The Hebrew University of Jerusalem.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
HPV Test
Allplex HPV28 Detection
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.